Advertisement
Advertisement

CHRO

CHRO logo

Channel Therapeutics Corporation

0.5673
USD
-0.0522
-8.43%
Dec 18, 14:50 UTC -5
Open

Channel Therapeutics Corporation Profile

About

Channel Therapeutics Corporation is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The Company's initial clinical focus is to selectively target the sodium ion-channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain and post-surgical nerve blocks. Channel Therapeutics Corporation, formerly known as Chromocell Therapeutics Corporation, is based in FREEHOLD, N.J.

Info & Links

CEO

Francis Knuettel

Headquarters

4400 Route 9 South, Suite 1000
Freehold, NJ 07728, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.chromocell.com

Auditor

Marcum LLP

Share holders

23

Employees

4

Channel Therapeutics Corporation Statistics

Valuation Measures

Market Capitalization2

3.42M

Enterprise Value

4.45M

Enterprise Value/EBITDA(ttm)

-0.50

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

925.30%

Return on Assets(ttm)

-453.90%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-8.89M

Net Income Available to Common(ttm)

-10.07M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

26.30%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

6.03M

Dividend Yield

0.00%

Float4

5.04M

% Held by Insiders

16.40%

% Held by Institutions

77.96%

Balance Sheet

Total Cash(mrq)

1.25M

Total Cash Per Share(mrq)

0.21

Total Debt(mrq)

2.29M

Total Debt/Equity(mrq)

-160.25%

Current Ratio(mrq)

0.60%

Quick Ratio(mrq)

0.60%

Book Value Per Share(mrq)

-0.25

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.88

Free Cash Flow(ytd)

-5.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement